针对组织因子的近红外光免疫疗法:一种针对恶性瘤的多功能治疗方法
Seiichiro Takao1, Hiroshi Fukushima1, Aki Furusawa1
1Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892, USA.
Cancer immunology, immunotherapy : CII
|January 3, 2025
概括
这项研究表明,针对组织因子 (TF) 的近红外光免疫疗法 (NIR-PIT) 能够有效地杀死各种癌细胞. 这种新型的癌症治疗抑制了瘤生长,并改善了小鼠模型的生存率.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物医学工程 生物医学工程
背景情况:
- 组织因子 (TF) 是一种参与血液凝固和癌症进展的蛋白质.
- TF在各种癌症类型中表达,使其成为潜在的治疗点.
- 近红外光免疫疗法 (NIR-PIT) 是一种新兴的癌症治疗方式.
研究的目的:
- 开发和评估一个针对TF的NIR-PIT,用于治疗多种癌症类型.
- 在体外和体内,评估针对TF的NIR-PIT的疗效.
- 调查由TF向的NIR-PIT诱导的细胞死亡的潜在机制.
主要方法:
- 提索托马布 (一种TF抗体) 与IR700染料的结合.
- 在多个癌细胞系的体外试验 (A431,HPAF-II,HSC-2,HT1376-luc,MDAMB231,SKOV3-luc).
- 使用HPAF-II和A431异种移植小鼠模型进行体内评估.
主要成果:
- 所有测试的癌细胞系都表现出TF表达.
- 针对TF的NIR-PIT诱导的剂量依赖的癌细胞死亡在体外.
- 在体内研究显示瘤生长被抑制,生存率提高,以及癌细胞损伤的组织学证据.
结论:
- 针对TF的NIR-PIT是一种有前途的治疗策略,用于表达TF的癌症.
- 这种方法在多种癌症类型中显示出潜力.
- 对针对TF的NIR-PIT进行进一步的研究是有必要的,以获得临床应用.
更多相关视频
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
7.8K
11:05Tissue-simulating Phantoms for Assessing Potential Near-infrared Fluorescence Imaging Applications in Breast Cancer Surgery
Published on: September 19, 2014
12.1K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
